Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:08 pm Purchase | 2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Commodore Capital LP | 5,419,896 7.800% | 1,890,431 (+53.56%) | Filing History |
| 2022-02-14 4:07 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 2,281,315 5.700% | 139,976 (+6.54%) | Filing History |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | Celcuity Inc. CELC | Commodore Capital LP | 920,464 6.200% | 89,497 (+10.77%) | Filing History |
| 2022-02-14 4:04 pm Purchase | 2022-02-04 | 13G | BELLUS Health Inc. BLU | Commodore Capital LP | 5,457,110 5.300% | 5,457,110 (New Position) | Filing History |
| 2021-11-03 5:31 pm Purchase | 2021-10-07 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 2,141,339 5.400% | 2,141,339 (New Position) | Filing History |
| 2021-10-19 5:20 pm Purchase | 2021-10-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Commodore Capital LP | 3,208,761 10.200% | 1,089,516 (+51.41%) | Filing History |
| 2021-07-12 2:44 pm Purchase | 2021-06-30 | 13G | CymaBay Therapeutics, Inc. CBAY | Commodore Capital LP | 3,529,465 5.100% | 3,529,465 (New Position) | Filing History |
| 2021-07-09 09:00 am Purchase | 2021-06-29 | 13G | Celcuity Inc. CELC | Commodore Capital LP | 830,967 6.600% | 830,967 (New Position) | Filing History |
| 2021-03-31 07:14 am Purchase | 2021-03-22 | 13G | Genocea Biosciences, Inc. GNCA | Commodore Capital LP | 2,871,624 5.400% | 2,871,624 (New Position) | Filing History |